Ownership
Private
Employees
~320
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Alimentiv General Information
Alimentiv (formerly Robarts Clinical Trials) specializes in global gastrointestinal clinical research. It has established itself as an industry leader in the design and execution of studies in inflammatory bowel disease and related GI conditions. The company collaborates with major pharmaceutical companies worldwide and academic institutions to deliver innovative trial designs, central imaging solutions, and precision medicine approaches.
Contact Information
Primary Industry
Contract Research Organization
Corporate Office
London, Ontario
Canada
Canada
Drug Pipeline
No pipeline data available
Key Partnerships
Collaborates with six of the world’s ten largest pharmaceutical companies; works with over 1,200 hospitals/clinics globally. Specific partners are confidential.
Alimentiv Funding
No funding data available
To view Alimentiv's complete valuation and funding history, request access »
Gosset